Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Oct 09, 2022 11:17am

227 Views

Post# 35014757

Pipeline web page: Additional Virus Targets

Their intention is for real, no doubt, as they took time to add the following section on their pipeline page:

ABOUT

Additional Virus Targets - SARS - CoV-2 - COVID-19

Pipeline | Theralase Technologies Inc. – Theralase Technologies

and also here: https://theralase.com/invest/ (Vaccine for various enveloped viruses)

So fair to assume that they had excellent feedback/interest from the High Containment Respiratory Virus Group, Special Pathogens, PHAC.

<< Previous

Bullboard Posts

Next >>

Pembina Pipeline and Haisla Nation finalize Indigenous-owned Cedar LNG